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1. Introduction  
With recent advances in tissue engineering, regenerative medicine, cell transplantation, stem 
cell therapy, and assisted reproduction, the living cell is becoming increasingly important as 
a tool for drug screening and therapy in modern medicine (Gearhart 1998; Langer and 
Vacanti 1993). As a result of their capability of differentiating into any type of cells, the 
pluripotent embryonic stem (ES) cells are of particular importance to the modern cell-based 
medicine (Gearhart 1998). However, ES cells may differentiate gradually during passaging 
when cultured at 37 oC. Therefore, for the eventual success of using ES cells in the emerging 
cell-based medicine, it is of great importance to maintain their pluripotency in the long term 
without passaging and in a cost effective way so that the cells can be widely distributed and 
readily available to end users in both research and clinical settings. This can be done by cell 
preservation to put the cells in a state of suspended animation, which can be achieved by 
either cooling the cells to preserve (cryopreservation) at a cryogenic temperature and/or 
drying the cells to preserve (lyopreservation) at ambient temperature (Acker 2004; Blow 
2009; Coger and Toner 2000; Toner and Kocsis 2002). In either case, the cells must enter 
(before being damaged) an amorphous (or glassy) phase, a thermodynamically metastable 
state with an extremely high viscosity and low molecular mobility and activity to arrest any 
biophysical and biochemical activities within the cells. Although contemporary methods for 
cell prservation still rely on the use of cryogenic tempertaure (cryopreservation), cell 
lyopreservation at ambient temperature is gaining more and more attention, due to the 
relatively high cost of maintaining and difficulty of transporting cryopreserved cells in 
cryogenic fluids such as liquid nitrogen (Acker 2004; Blow 2009; Deb 2009; Kanias and Acker 
2006; Meyers 2006). In this chapter, the fundamentals and recent advancement of both cryo 
and lyopreservation are first summarized, followed by a critical review of the progress and 
challenges in applying the various cell preservation strategies to maintain the pluripotent 
properties of embryonic stem cells in the long term. This chapter is concluded with an 
outlook of the future directions of embryonic stem cell preservation. 
2. Cryopreservation at cryogenic temperatures 
Cell cryopreservation can be achieved by either slow-freezing or vitrification (Coger and 
Toner 2000; Fahy et al. 1984; Mazur 1984; Rall and Fahy 1985). The former relies on the 
formation of extracellular ice (the crystalized state of water) to freeze concentrate the 
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extracellular solution in the presence of a low concentration (< ~ 2 M) of cryoprotectants (or 
cryoprotective agents, or CPAs for short) such as glycerol, ethylene glycol, PROH (1,2-
propanediol or propylene glycol), and DMSO (dimethylsulfoxide). As a result, the cells 
gradually dehydrate due to osmosis during freeezing and enter a glassy phase suitable for 
long-term storage. While slow-freezing  is to vitrify what is within the cells in the presence 
of extracellular ice,  the goal of vitirfication is to have both intra and extracellular water 
enter the amorphous, glassy phase to eliminate any potential damaging (either mechanical 
or physicochemical) effect  of ice foramtion. Conventionally, vitrification is achieved by 
using an unusually high concentration (up to 7 M) of CPAs, which can cause significant 
metabolic and osmotic injury to living cells. As a result, various approaches have been 
investigated to achieve vitrification of living cells at a low concentration of CPAs such as 
that used for slow-freezing, which is called low-CPA vitrification. The three approaches 
mentioned above for cell cryopreservation can be best demonstrated in an extended phase 
diagram of temperature versus solute concentration (Fig. 1), which consists of four regimens 
representing four probable phases (liquid, subcooled liquid, supersaturated liquid, and the 
solid-like amorphous or glassy phase) of an aqueous solution. The four lines that separate 
the four regimens are called liquidus (between liquid and subcooled liquid), extended  
 
 
Fig. 1. An illustration on the extended phase diagram of the various methods for cell 
preservation at either cryogenic or ambient temperature from an initial (stable) liquid state 
(A) to a final glassy phase (I, II, III, or IV): The phase diagram is divided into four 
thermodynamic regimens by the liquidus, extended liquidus, solidus, and the line of glass 
transition; the four regimens are the liquid, subcooled liquid, supersaturated liquid, and the 
glassy phase; cells must enter the glassy phase for long-term storage; CPA represents 
cryoprotectant, and θg and θm represent the glass transition and melting temperature of pure 
sugar/CPA used as lyoprotectant or CPA, respectively. Of note, the diagram is not to scale 
(for example, the melting temperature of pure CPAs is usually below 20 oC) 
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liquidus (between subcooled liquid and supersaturated liquid), solidus (between liquid and 
supersaturated liquid), and the glass transition line (between the glassy phase and the 
unstable liquid that is either subcooled or supersaturated). A detailed description of the 
three processes of cell cryopreservation is given below. 
2.1 Slow-freezing 
For the conventional slow-freezing approach, the following steps are typically used 
(A→B→C→D→E→I in Fig. 1): (1), cells in an aqueous solution (state A) are first loaded with 
CPAs at a concentration usually up to 15 wt% (or up to ~ 2 M, state B); (2), the cells are then 
subcooled usually down to between -2  and -7 oC (C) to seed ice in the extracellular space by 
touching the sample contained usually in a cryovial with a deeply cooled (e.g., in liquid 
nitrogen) object (C→D); (3), the cells are further cooled slowly (typically, < 10 oC/min) along 
the liquidus and (if necessary) extended liquidus to between -40 and -100 oC, a process 
called freeze concentration (D→E); and (4), the cells in the frozen sample are transferred into 
liquid nitrogen for long-term storage (E→I). 
During the slow-freezing process, the formation of extracellular ice after ice-seeding leads to 
freeze concentration of the unfrozen solutions by ejecting solutes and cells from the frozen 
to unfrozen phase (note: unlike pure water that becomes frozen at a specific tempertaure, 
solutions become frozen over a temperature range that is dependent on the types of solutes 
in the solution). As a result, dehydration of cells in the unfrozen phase driven by osmosis 
ensues, which minimizes intracellular water available for ice formation inside the cells so 
that the cells can enter the glassy phase (I) when transferred into liquid nitrogen. This 
approach typically requires a specialized machine usually called controlled rate freezer 
(CRF) to achieve freezing in a controllable manner. The time required for the slow-freezing 
process is typically in hours. 
2.2 Conventional vitrification 
Vitrification by definition is ice free. In other words, no (or negligible) ice formation or 
freezing will occur in the sample during cooling (Fahy et al. 1984; Fahy et al. 2004b; Rall and 
Fahy 1985). Conventional vitrification (A→F→II in Fig. 1) has also been studied for 
cryopreservation of both cells and tissue. In this approach, biological samples (state A) are 
first loaded with a very high concentration of CPAs (up to ~ 7 M, state F) (Fahy et al. 1984; 
Fahy et al. 2004b; Rall and Fahy 1985). The samples are then cooled directly from ambient 
temperature to a cryogenic temperature usually in liquid nitrogen (state II) and stored there 
for future use.  
Although the conventional vitrification approach can be used to eliminate the detrimental 
effect of ice formation altogether, the unusually high CPA concentration required by the 
approach is toxic to most mammalian cells even in a short period of exposure (ranging from 
seconds to minutes dependent on the specific cells and tissues) (Chen et al. 2000; Chen et al. 
2001a; Fahy et al. 2004a; Fowler and Toner 2005; Heng et al. 2005; Hunt et al. 2006). 
Therefore, the samples should be cooled as soon as possible after loading with CPAs. 
Oftentimes, a mixture of multiple CPAs is used to reduce the cytotoxicity of the high CPA 
concentration required (Fuller 2004). In addition, large, membrane impermeable molecules 
such as sugars (typically sucrose and trehalose) have been used to dehydrate the cells 
somewhat before cooling and protect cell membrane from injury during cooling (Beattie et 
al. 1997; He et al. 2008b). Vitrification can be done without a specialized machine and the 
time required is much shorter than that for slow-freezing. 
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2.3 Low-CPA vitrification 
Low-CPA vitrification (A→B→III in Fig. 1) is a further advancement of the conventional 
vitrification with the goal to reduce the CPA concentration (e.g., at state F versus B) required 
for vitrification to a low, nontoxic level (similar to that used in slow-freezing). This can be 
done by creating an ultrafast cooling rate to cool the cells for cryopreservation. This is 
because the higher the cooling rate, the less the amount of cryoprotectants is required for 
achieving vitrification (Berejnov et al. 2006; Boutron 1986; He et al. 2008b; Karlsson et al. 
1994; Toner et al. 1990; Yang et al. 2009). For example, even pure water can be vitrified 
without any ice formation when the cooling rate is approximately one million degree 
Celsius per second (Bhat et al. 2005; Bruggeller and Mayer 1980; Yang et al. 2009).  
Various devices have been utilized to achieve fast cooling rates (up to ~ 20,000 oC/min) such 
as the traditional French type straw (Fig. 2), open pulled straw, electron grid, and cryoloops 
(Fowler and Toner 2005; Gardner et al. 2007; Vajta and Nagy 2006; Yavin and Arav 2007). As 
a result, the amount of cryoprotectant required for vitrification can be reduced to around 4 
M. To achieve an ultrafast cooling rate, two recent studies reported the use of a micro-
fabricated oscillating heat pipe (OHP) device (Han et al. 2008; Jiao et al. 2006). Although 
their theoretical analysis shows that a cooling rate of ~ 106 oC/min could be achieved, 
testing of the device for low-CPA vitrification using living cells has not been reported to 
date. Another recent study reported that a cooling rate as high as ~ 200,000 oC/min can be 
achieved by plunging an ultra-thin walled (10 μm) quartz microcapillary (QMC, 180 μm 
inner diameter that is slightly bigger than a human oocyte, Fig. 2) into liquid nitrogen (He et 
al. 2008b). As a result, the CPA concentration required for vitrification of mouse ES cells  
and mouse oocytes can be reduced to as low as 2.5 M altogether (He et al. 2008b; Lee et al. 
2010), which is close to the highest CPA concentration usually used for slow-freezing.  
 
 
Fig. 2. (Adapted from (He et al. 2008b)) A comparison of the conventional French-type straw 
(top) used today for cell vitrification at an unusually high CPA concentration and the 200 
µm (outer diameter), thin-walled (10 µm) quartz microcapillary (QMC, bottom) used to 
achieve ultrafast cooling to minimize the CPA concentration required for vitrification 
Another way to improve cell vitrification is to confine cells in a small space such as sub-
milimeter (in diameter) sized liquid droplets of aqueous cell suspension (Berejnov et al. 
2006; Edd et al. 2008; Franks et al. 1983). A major disadvantage of using small liquid droplets 
to confine cells is that the droplets will merge with each other unless they are dispersed in 
an oil phase, which makes it difficult to retrieve cells from the droplets. 
The hydrogel microcapsule (~250-1000 µm) of natural, biocompatible polymers such as 
alginate has been widely explored to confine or encapsulate a variety of living cells for 
transplantation and cell-based therapy (Chang 1996; Maguire et al. 2006; Magyar et al. 2001; 
Orive et al. 2003; Orive et al. 2004; Orive et al. 2006; Rohani et al. 2008; Torre et al. 2007; 
Wang et al. 2006a; Wang et al. 2006b). Recently, living cells have been encapsulated in even 
smaller (~100 µm) microcapsules for better cell survival and transplanation effcacy (Zhang 
and He 2009). These microcapsules can well retain their morphology for an extended period 
of time in physiologic solutions both in vitro and in vivo. However, cryopreservation of cells 
Conventional straw
Quartz microcapillary (QMC)
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encapsulated in the large (≥ ~ 250 µm) microcapsules by slow-freezing has been challenging 
because the inevitable ice formation always results in significant damage to the 
microcapsules, which in turn can damage the encapsulated cells (Heng et al. 2004; Herrler et 
al. 2006; Stensvaag et al. 2004; Wu et al. 2007). Although the conventional vitrification 
approach can overcome this problem, the unusually high concentration CPA needed is 
detrimental to stress-sensitive cells such as the ES cells (Fahy et al. 1987; Fahy et al. 1984; 
Fahy et al. 2004b; Rall and Fahy 1985; Wu et al. 2007). 
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Fig. 3. (Adapted from (Zhang et al. 2010)) Typical morphology of alginate microcapsules 
after cryopreservation in physiological saline with (A) 0, (B) 0.7, and (C) 1.4 M DMSO 
(dimethylsulfoxide); typical scanning calorimetry data for samples with (D) 0, (E) 0.7, and 
(F) 1.4 M DMSO; and (G) the ratio of peak area on the scanning calorimetry data for samples 
with microcapsules (~ 30% in volume) to that of samples without microcapsules at various 
CPA concentrations: Cooling rate, 100 oC/min 
By careful cryomicroscopy and scanning calorimetry studies, it was identified in a recent 
publication that water enclosed in ~100 µm (in diameter) alginate microcapsules can be 
preferentially vitrified over the bulk water (where the microcapsules are suspended) with 
only 1.4 M DMSO at a cooling rate of 100 oC/min (Zhang et al. 2010). Typical results from 
the cryomicroscopy studies are shown in Fig. 3 for microcapsules cryopreserved with (A) 0, 
(B) 0.7, and (C) 1.4 M DMSO. The microcapsules appeared intact post cryopreservation 
when the DMSO concentration was 1. 4 M (C) (or higher) while they were damaged 
(wrinkled) when ≤ 0.7 M DMSO was used (A and B). The wrinkled appearance of 
microcapsules in (A) and (B) presumably was a result of significant ice formation in the 
microcapsules during freezing. Since water in the bulk solution was frozen under all the 
conditions, the data suggest that water enclosed in the microcapsules was preferentially 
vitrified in the presence of 1.4 M DMSO resulting in the intact morphology in (C). 
The calorimetry data are also shown in Fig. 3 for samples with (D) 0, (E) 0.7,  and (F) 1.4 M 
DMSO either in the absence or presence of ~ 30% (by volume) alginate microcapsules. The 
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area of the major peak on the heat flux curve for each sample is proportional to the amount 
of ice formed in the sample. Clearly, the amount of ice formed in samples with and without 
microcapsules was not significantly different when the DMSO concentration was ≤ 0.7 M (D 
and E), suggesting ice formed equally in the bulk solution and the microcapsules resulting 
in damage to the microcapsules shown in Fig. 3A and B. When the DMSO concentration was 
increased to 1.4 M, however, the peak area for samples with microcapsules was much 
smaller than that for samples without microcapsules (Fig. 3F), indicating much less ice 
formation in the samples with microcapsules. Presumably, the reduced ice formation in the 
samples with microcapsules was due to vitrification of water enclosed in the microcapsules 
resulting in the intact microcapsules shown in Fig. 3C. 
The ratio of the peak area for samples with ~ 30% (by volume) microcapsules to that of 
samples without microcapsules was further quantified and is shown in Fig. 3G. The ratio 
was not different from 1, suggesting equal ice formation in the bulk solution and the 
microcapsule when the DMSO concentration was ≤ 0.7 M. When the DMSO concentration 
was 1.4 M, the ratio was ~ 0.7 suggesting that water encloased in the microcapsules (30% by 
volume) were preferentially vitrified under this condition. When further increasing DMSO 
to 2.1 M, the ratio increased back to 0.91, presumably due to the vitrification of more bulk 
water. Therefore, water enclosed in the microcapsules can be preferentially vitrified in the 
presence of 1.4 M DMSO while more than 2.1 M DMSO is required to vitrify the same 
amount of water in the bulk solution, indicating the capability of alginate microcapsules in 
enhancing vitrification of the enclosed water even at a cooling rate of 100 oC/min. The 
preferential vitrification of water enclosed in the microcapsule is due to its higher viscosity 
(Ahearne et al. 2005; Qin 2008; Zhang et al. 2006) and small volume (sub-nanoliter) and is 
expected to be much more significant at much higher cooling rates (e.g., > 10,000 oC/min) 
(Chen and Li 2008; Karlsson et al. 1994; Yang et al. 2009; Zhang et al. 2010; Zhao et al. 2006). 
The preferential vitrification of water enclosed in small alginate microcapsules 
demonstrated in Fig. 3 should be able to enhance vitrification of living cells encapsulated in 
the microcapsules at high cooling rates (e.g., > 10,000 oC/min). This is because it can not 
only depress ice formation and growth in the microcapsule but also prevent ice (if any) 
propagation into cells from the bulk solution where ice is usually formed first (because of its 
much bigger volume) (Berejnov et al. 2006; Fahy et al. 1987; Franks et al. 1983; He et al. 
2008b; Karlsson et al. 1994; Mazur et al. 2005a; Mazur et al. 2005b; Toner 1993; Toner et al. 
1990; Yavin and Arav 2007). This hypothesis is confirmed by a recent study where the 
C3H10T1/2 mouse mesenchymal stem cells encapsulated in ~100 µm alginate 
microcapsules were vitrified using a 400 µm, thin-walled quartz microcapillary at a low-
CPA concentration (1.4 M DMSO) (Zhang et al. 2010). Typical images of the cells are shown 
in Fig. 4 for both before (A-D) and after (E-H) the low-CPA vitrification procedure. 
Before vitrification, both the non-encapsulated (A and B) and microencapsulated (C and D) 
cells remained alive, indicating that the microencapsulation process did not result in any 
significant damage to the cells. After vitrification, many of the non-microencapsulated cells 
appeared swollen with damaged plasma membrane (E) and were significantly injured (red, 
F) with a cell viability of 42.0 ± 4.4%. For the microencapsulated cells, however, most of 
them appeared intact (G) and viable (green, H) after vitrification. The viability of the 
microencapsulated cells post cryopreservation was determined to be 88.9 ± 2.9%, which is 
more than twice of that of the non-encapsulated cells and is only ~ 5% less than that before 
vitrification. 
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Fig. 4. (Adapted from (Zhang et al. 2010)) Typical phase and fluorescence images of non-
encapsulated (A, B, E, and F) and microencapsulated (C, D, G, and H) cells before (A-D) and 
after (E-H) cryopreservation by low-CPA vitrification. In the fluorescence micrographs, live 
and dead cells were stained green and red, respectively. Scale bars: 100 µm 
After liquefying the microcapsules, the collected cells were found to attach well with an 
attachment efficency (ratio of the number of cells attached in the cryopreserved samples to 
that in the control fresh samples at day 1, one day after seeding the cells) of ~ 85 and 37% for 
the microencapsulated and non-microencapsulated cells, respectively (Fig. 5).  Moreover, 
the viable cells with low-CPA vitrification proliferate normally just like the control fresh 
cells (Fig. 5). These data clearly demonstrate the capability of the small alginate 
microcapsule in protecting cells from injury during low-CPA vitrification, presumably by 
minimizing ice formation (or enhancing vitrification) in the microencapsulated cells.  
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Fig. 5. Proliferation of the non-microencapsulated and microencapsulated mesenchymal 
stem cells in 3 days after vitrifcation using 1.4 M DMSO in the 400 µm quartz microcapillary 
together with control fresh cells without cryopreservation: The total number of cells seeded 
for each of the three conditions were the same 
(A) (B)
(E) 
(C)
(G) (H)
(D)
(F)
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3. Lyopreservation at ambient temperature 
The idea of dry or lyopreservation at ambient temperature is actually not new as many 
lower organisms, resurrection plants, and seeds can survive extreme drought in nature 
upon rehydration, a phenomenon called anhydrobiosis or life without water (Armstrong 
July, 1996; Browne et al. 2002; Clegg 2001; Crowe and Cooper 1971; Crowe and Crowe 2000; 
Crowe et al. 2004; Crowe et al. 1992; Perry 1999). A high concentration of small sugars 
(disaccharides typically sucrose for plants and trehalose for lower organisms) have been 
found in these organisms and plants when they are in the anhydrobiotic (or desiccated) 
state. Learning from nature, both sucrose and trehalose have been investigated as the 
protective agent (also called lyoprotectant) in protocols of lyopreservation (Crowe and 
Crowe 2000; Crowe et al. 2001; Crowe et al. 2005; Eroglu et al. 2000; Wolkers et al. 2002). 
Two methods of desiccation have been studied to dry cells in aqueous samples for 
lyopreservation: evaporative drying and freeze-drying (or lyophilization) which are 
illustrated in Fig. 1 as well. 
3.1 Evaporative drying 
During desiccation by evaporative drying (A→B→IV in Fig. 1), water in an aqueous sample 
with cells is removed by exposing the sample to a dry environment (e.g., dry air, inert gas 
such as nitrogen, or vacuum) without freezing (or ice formation) after loading with up to ~ 
15 wt% lyoprotectants. Forced convection is usually used to increase the drying rate of 
natural convection. Desiccation by evaporative drying has been used to achieve 
lyopreservation of biomacromolecules such as proteins and lipids, pharmaceutical drugs,  
 
A B 
 
Fig. 6. (Adapted from (Aksan et al. 2006) and (He et al. 2008a)) (A) Evaporative drying of 0.2 
M aqueous trehalose solution in micorchannels: The brightness in the solution in the lower 
panel indicate the viscosity of solution (the stronger the intensity, the higher the viscosity is 
in the solution), which clearly shows a glassy skin formed on the interface between the 
solution and the dry nitorgen gas (N2) during drying and the heterogeneity of viscosity in 
the residual solution; and (B) predicted diffusivity in the trehalose sloution during 
evaporative drying at various times: The glassy skin forms after 3 minutes drying and has 
an extremely low diffusivity while the diffusivity in the rest of the solution is much higher, 
indicating a significant residual water in the dried residual solution 
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prokaryotic cells (microbials), and blood cells (red cells and platelets), but not eukaryotic 
mammalian cells. 
A major engineering difficulty to dry the glass-forming disaccharide solution for cell 
lyopreservation by evaporative drying is that a thin glassy skin can easily form on the 
interface between the solution and the dry environment (Fig. 6A). The glassy skin has an 
extremely high viscosity and low diffusivity (Fig. 6B) leading to incomplete drying (up to 
20% residual water after hours drying) and heterogeneity in the evaporatively dried sample. 
This problem might be alleviated by breaking up the solution into micron or submicron 
sized droplets or thin-films (He et al. 2008a). 
3.2 Freeze-drying 
A typical freeze-drying process is illustrated in Fig. 1 as A→B→C→D→G→ H→IV: (1), cells 
in an aqueous solution (state A) is first supplemented with lyoprotectants at a concentration 
of up to ~ 15 wt% (state B); (2), the sample is subcooled to usually between -2 and -7 oC (C)  
to seed extracellular ice in the sample by touching the sample with a deeply cooled object 
(C→D); (3), the sample is further cooled to between -30 and -50 oC slowly at a cooling rate 
usually less than 10 oC/min (D→G); (4), the ice formed in the sample during freezing is then 
sublimated (i.e., from solid ice crystal to vapor directly without going through the liquid 
water phase) by exposing the sample to a vacuum usually less than 10 Pa at the phase G 
(primary drying); and (5) a secondary drying process is then done by heating the sample in 
vacuum slowly to ambient temperature to further dehydrate the sample for additional 
hours to days (G→H→IV). The samples are then sealed and preserved in the dry phase (IV) 
at ambient temperature for future use. Freeze-drying has been used successfully in 
achieving lyopreservation of many biomacromolecules such as proteins and lipids and 
many pharmaceutical drugs. It has also been used for lyopreservation of prokaryotic cells 
such as microbials and blood cells including the red cells and platelets, but not eukaryotic 
cells at this time. 
For freeze-drying, it is crucial to keep the temperature below the so-called collapse 
temperature (TC) (Abdul-Fattah et al. 2007; Bellows and King 1972; Felix 2007; Fonseca et al. 
2004a; Fonseca et al. 2004b; Gieseler et al. 2005; Kramer et al. 2009; MacKenzie 1966; Meister 
and Gieseler 2006; Meister et al. 2006; Nail et al. 2002; Pikal 1985; Pikal and Shah 1990; Pikal 
et al. 1983; Rey and May 1999)) during primary drying (at the phase G). Otherwise, the 
sample may collapse during primary drying (Fig. 7A) and blow up during secondary drying 
(Fig. 7B), resulting in incomplete drying and heterogeneity (Fig. 7C versus D) in the freeze-
dried product as that in evaporatively dried sample. Consequently, the biostability of the 
freeze-dried biologicals could be significantly compromised (Hancock et al. 1995; He et al. 
2008a; He et al. 2006b). More importantly, a recent study reported that the collapse 
temperature of cell culture medium-based trehalose solutions important for freeze-drying 
mammalian cells can be much lower than that of a simple binary trehalose-water solution 
(TC = ~ -30 oC) and trehalose solutions used for freeze-drying pharmaceuticals and 
prokaryotes (Yang et al. 2010a), as shown in Fig. 7E. 
Beside the engineering challenge to effectively dry the trehalose solutions, effective delivery 
of the small hydrophilic lyoprotectants (trehalose and sucrose) into mammalian cells has 
been challenging as the first step toward cell preservation at ambient temperature. This is 
because lyoprotectants such as trehalose must be present both intra and extracellularly to 
provide the maximum protection during drying, but mammalian cells lack a mechanism to 
synthesize trehalose endogenously and their plasma membrane is impermeable to the 
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sugars (Acker 2004; Chen et al. 2001b; Eroglu et al. 2002).  Over the past decades, a number 
of approaches have been explored to introduce trehalose into living cells for preservation 
purposes. The most straightforward approach is to deliver exogenous trehalose into the 
cytosol of living cells by direct microinjection. This approach has been successfully used for 
intracellular delivery of trehalose to cryopreserve mammalian oocytes that have a large size 
(~ 100 μm in diameter) and are generally limited in quantity (less than a few hundred) 
(Bhowmick et al. 2002; Eroglu et al. 2005; Eroglu et al. 2003; Eroglu et al. 2002). 
 
(E) 
(A) 
(B) 
(C) (D) 
 
Fig. 7. (Adapted from (Yang et al. 2010a)) (A) Typical photograph showing collapsed vs. 
intact sample after primary drying (at -38 oC) of 0.2 versus 0.4 M trehalose in DMEM with 
10% fetal bovine serum; (B) the collapse sample blew up during secondary drying (heating 
at 0.5 oC/min to room tempertaure) as a result of the evaporation of the significant residual 
water after primary drying while the non-collapsed sample appeared intact; SEM (scanning 
electron microscopy) images showing homogeneous microporous structure in the intact 
sample (C) and heterogeneous microstructure in the collapsed and blew-up sample (D) after 
secondary drying; and the collapse tempertaure (TC) as a function of trehalose concentration 
in various solutions: DMEM, Dulbecco‘s modified eagle medium (aqueous) widely used for 
culturing mammalian cells 
However, the microinjection approach is difficult (if not at all impossible) to apply for most 
living cells that are generally much smaller (< ~ 20 μm) than mammalian oocytes and 
usually present in a large quantity (millions). Small living cells have been genetically 
engineered to synthesize trehalose endogenously. This approach requires the constant 
production of adenoviral vectors that exhibit significant cytotoxicity, particularly at high 
multiplicities of infection (Gordon et al. 2001; Guo et al. 2000; Puhlev et al. 2001). Trehalose 
has also been introduced into mammalian cells or their organelles through engineered or 
native transmembrane pores (Acker et al. 2003; Chen et al. 2001b; Elliott et al. 2006; Eroglu et 
al. 2000; Liu et al. 2005), electroporation (Reuss et al. 2004; Shirakashi et al. 2002), fluid-phase 
endocytosis (He et al. 2006a; Oliver 2004; Wolkers et al. 2003), and lipid phase transition 
(Beattie et al. 1997; He et al. 2006a). 
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In spite of the various approaches being explored, a consistent report of cell preservation 
using trehalose for small eukaryotic living cells is still absent (Acker 2004; Crowe 2007; 
Crowe et al. 2005; Kanias and Acker 2006). This could be due to the inability to deliver a 
sufficient amount of intracellular trehalose (≥ ~ 0.1 M) for cell preservation using some of 
the approaches (e.g., fluid phase endocytosis). In addition, cells could be too severely 
compromised during the delivery step to withstand further freezing/dehydration stresses 
during preservation, considering the highly invasive nature of some of the approaches (e.g., 
electroporation). Recently, research has been sought to use nanoparticles (liposome and 
polymeric nanocapsules) as the intracellular delivery vehicles of the small hydrophilic 
lyoprotectants with promising outcomes (Holovati and Acker 2007; Holovati et al. 2009; 
Scott 2006; Zhang et al. 2009). 
Besides the non-reducing disaccharides (trehalose and sucrose), small stress proteins 
particularly, the late embryogenesis abundant (LEA) proteins have been suggested to be an 
important part of the molecular repertoire that renders desiccation tolerance in 
anhydrobiotic organisms and are attracting more and more research attention (Browne et al. 
2002; Clegg 2001; Crowe and Crowe 2000; Crowe et al. 2004; Crowe et al. 1992; de Castro et 
al. 2000; Hand et al. 2007; Huang and Tunnacliffe 2007; Iturriaga 2008; Li and He 2009; Perry 
1999; Tunnacliffe et al. 2001). 
4. Biophysics in cell preservation 
As mentioned above, one or more protective agents (cryo and lyoprotectants for cryo and 
lyopreservation, respectively) are required to protect cells from being damaged during 
preservation. Although it has not been well established, the mechanism of protection provided 
by these agents is usually hypothesized to be three folds: 1) acting as water to form hydrogen 
bonds with proteins and lipids so that their functional conformations can be preserved during 
water deficit (Clegg et al. 1982; Crowe 1993a; Crowe 1993b; Crowe et al. 1998), 2) promoting 
preferential hydration of the biomacromolecules in cells during water loss (Cottone 2007; 
Cottone et al. 2005; D'Alfonso et al. 2003; Roche et al. 2006), and 3) forming a stable glassy 
matrix with extremely low molecular mobility to prevent the 3D intracellular structure from 
collapse and to suspend any degradative and metabolic reactions in response to water loss 
(Crowe et al. 1998; Crowe et al. 2001; He et al. 2006b; Sun et al. 1996). 
At the cellular level, two biophysical events (cell dehydration and intracellular ice formation 
(IIF)) have been well established to be the major causes of cell injury. During slow-freezing, 
these two biophysical events result in the classical inverted U-curve of cell survival as a 
function of cooling rate during freezing with the cell survival being the highest at the 
optimal cooling rate (CRSF), as demonstrated in Fig. 8. At a very slow cooling rate (< CRSF), 
cell dehydration induced biochemical/biophysical alterations are the dominant mechanism 
of cell injury while at a not-so-high cooling rate (< CRV), cells are mainly damaged by IIF. 
With the further increase of cooling rate to higher than CRV, the kinetics of cooling is faster 
than that of both IIF and cell dehydration and cell injury due to both events is minimized. 
As a result, the cell survival increases with the increase of cooling rate till it reaches 100%. 
Both CRSF and CRV are dependent on the cell type, the CPA type (propylene glycol has been 
reported to be superior to ethylene glycol in terms of the capability of vitrification (He et al. 
2008b)), and the CPA concentration. Of note, the damaging (both osmotic and metabolic) 
effect of an unusually high concentration of CPAs required by the conventional vitrification 
is not considered in the figure. 
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Fig. 8. Cell survival accounting for the effect of intracellular ice formation (IIF, |), cell 
dehydration (~), the combination of IIF and cell dehydration at both low (for slow-freezing, 
¡) and high  (for vitrification, ¢) cooling rates. At a very slow cooling rate (< CRSF), cell 
dehydration induced biochemical/biophysical alterations are the dominant mechanism of 
cell injury while at not-so-high cooling rates (< CRV), cells are mainly damaged by IIF; with 
the further increase of cooling rates to higher than CRV, cell injury due to both cell 
dehydration and IIF is negligible. Both CRSF and CRV are dependent on the cell type, the 
CPA type, and the CPA concentration. Of note, the damaging (both osmotic and metabolic) 
effect of an unusually high concentration of CPAs required by the conventional vitrification 
is not considered in the figure 
Bothe cell dehydration and IIF can be quantified by modeling. IIF has been studied using 
both phenomenological and mechanistic models (Pitt 1990; Toner 1993). The mechanistic 
model has been widely used and delineates the ice formation process as two consecutive 
events: (1) Nucleation to form ice nuclei and (2) the subsequent growth of the nuclei (Hobbs 
1974; Toner 1993). Nucleation of intracellular ice can be catalyzed by either a surface (surface 
catalyzed nucleation, SCN) such as the cell plasma membrane or a volume of subcooled 
solution (volume catalyzed nucleation, VCN) such as the cytoplasm (Hobbs 1974; Toner 
1993). The rate of ice nucleation (I) due to either VCN or SCN can be estimated as follows 
(Toner et al. 1990; Toner et al. 1992): 
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where Tf is the equilibrium freezing point of the intracellular solution, N is the number of 
water molecules either in the cells (for VCN) or in contact with the cell plasma membrane 
(for SCN), η is viscosity, Ω and κ are two model parameters that are usually called the 
kinetic and thermodynamic model parameter, respectively, and the subscript 0 represents 
the isotonic solution state. The two model parameters (constants) under isotonic solution 
state (Ω0 and κ0) need to be determined a priori by experimental studies and have been 
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reported in the literature for a number of cell types as summarized elsewhere (He and 
Bischof 2003; Toner 1993; Yang et al. 2010b). The cumulative probability of intracellular ice 
formation (PIIF) can then be calculated as follows (Toner 1993; Toner et al. 1990): 
 ( )01 exp tVCN VCNIIFP VI dt= − −∫  (2) 
 ( )01 exp tSCN SCNIIFP AI dt= − −∫  (3) 
 (1 )Tot SCN SCN VCNIIF IIF IIF IIFP P P P= + −  (4) 
where V and A are the cell volume and surface area available for catalyzing the nucleation 
of intracellular ice, respectively. Significant IIF is usually manifested as darkening of the cell 
cytoplasm when observed under a bright field of light microscopy, which has been used 
widely to quantify the kinetics of IIF (Diller 2005; Toner et al. 1991; Yang et al. 2010b).  
Of note, the above IIF model is valid only when the ice nucleation (the first step of IIF) is the 
rate-limiting step of IIF which is often true when freezing cells/tissues at not very high 
cooling rates (e.g., less than a few hundred Celsius per minute) and in the absence of a high 
concentration of CPA (e.g., less than 10 wt%) (Toner 1993). When cooling cells/tissue with 
much higher cooling rates and/or a high concentration of intracellular CPA (e.g., during 
vitrification and after significant cell dehydration during slow-freezing), the rate limiting-
step of IIF is the growth of the ice nuclei. The IIF under these conditions is said to be 
diffusion-limited for which more complicated models are needed to predict the amount of 
intracellular ice (Chen and Li 2008; Karlsson et al. 1993; Karlsson et al. 1994; Yang et al. 2009; 
Zhao et al. 2006). To better predict the diffusion-limited ice nucleation and growth, an 
advanced model such as the free volume model that can account for the effect of glass 
transition on solution viscosity and diffusion coefficient might be necessary. Such free 
volume models for several cryo and lyoprotectants have been reported in (He et al. 2006b).  
In order to predict the probability of IIF using the above model during slow-freezing 
where freeze concentration induced cell dehydration is significant, information on the cell 
volume, V (or cell surface area, A, related to the diameter of the cells when the cells 
assume a spherical geometry), during freezing is required. The following model has been 
commonly used to predict the cell volume change during freezing (Karlsson et al. 1994; 
Mazur 1963): 
 
1 1
ln
p g fb s
w b s s s w g ref
L AR T hdV V V V
dt V V V n R T Tν φ ν
⎡ ⎤⎛ ⎞Δ− −⎢ ⎥= − − −⎜ ⎟⎜ ⎟− − +⎢ ⎥⎝ ⎠⎣ ⎦
 (5) 
where νw is the partial molar volume of water, n represents amount (in mole), ϕs is the 
dissociation constant of solutes (e.g., 2 for NaCl), Vb is the osmotically inactive volume in 
cells, Δhf is the latent heat of fusion of water, Tref is a reference temperature (either ice-
seeding temperature or the equilibrium melting point of intracellular solution), T is thermal 
history, the subscripts s and w represent solute (including CPAs) and water, respectively, 
and Lp is the cell plasma membrane permeability to water that can be calculated as follows 
(Levin et al. 1976): 
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where Lpg is the permeability of the cell membrane to water at the reference temperature 
(Tref) and ELp is the activation energy for water transport across the cell plasma membrane. 
In the equation, Lpg and ELp are two model parameters (constants) that need to be 
determined a priori using experimental data. Cell dehydration during freezing can be 
measured using either a specialized cryostage mounted on a light microscope (Diller 2005; 
Toner et al. 1991) or differential scanning calorimetry (Bischof 2000; Devireddy et al. 2001; 
Devireddy et al. 1998; Luo et al. 2002). Many studies have been performed to determine the 
two model parameters for various cells, which have been reviewed and tabulated elsewhere 
(Bischof 2000; Han and Bischof 2004; He and Bischof 2003; Yang et al. 2010b). 
Although cell dehydration and intracellular ice formation (IIF) can be predicted using the 
above models, a quantitative understanding of the mechanistic link between the two 
biophysical events and cell injury has not been well established despite some early efforts in 
this respect as reviewed in (He and Bischof 2003). The incidence of significant IIF (defined as 
darkening of cell cytoplasm) correlates strongly with cell death in many cell types (i.e., 50% 
of IIF in many cell populations yields 50% of dead cells) (Toner 1993). However, the exact 
amount or percentage of intracellular ice that is significant enough to result in irreversible 
cell death is still unclear. Some studies even suggest that a small amount of intracellular ice 
might be beneficial to cell survival (Acker and McGann 2002; Acker and McGann 2003). 
Therefore, further studies to establish mechanistic models capable of accounting for the 
effect of all the freezing induced biophysical events including IIF and freeze concentration 
(i.e., the so-called solute effect), and low temperatures per se is important to further our 
understanding of low temperature biology and its biomedical applications such as 
cryosurgery and cryopreservation. 
5. Preservation of embryonic stem (ES) cells  
Currently, the two most commonly used approaches for ES cell cryopreservation are slow-
freezing and conventional vitrification (Hunt and Timmons 2007; Li et al. 2010; Martin-
Ibanez et al. 2008). A summary of the major advantages and drawbacks of the two 
approaches is given in Table 1. Although a low, non-toxic CPA concentration (usually ≤ ~ 
1.5 M) is used in slow-freezing, it is always associated with mechanical and physicochemical 
injury to cells due to ice formation and slow-freezing (usually ≤ 1 oC/min) induced cell 
dehydration (Bischof 2000; Gao and Critser 2000; Mazur 1984; Toner 1993). The conventional 
vitrification approach diminishes ice formation altogether to a harmless level (Fahy et al. 
1987; Fahy et al. 1984; Fahy et al. 2004b; Rall and Fahy 1985; Wu et al. 2007). The unusually 
high (as high as 7 M) concentration of CPA required, however, can result in significant 
metabolic and osmotic injury to cells (Chen et al. 2000; Chen et al. 2001a; Fahy et al. 2004a; 
Fowler and Toner 2005; Heng et al. 2005; Hunt et al. 2006). Consequently, it is necessary to 
use multiple steps of CPA loading/dilution and maintain a short exposure time (within a 
few minutes) to high concentration CPA in each step to minimize injury (Reubinoff et al. 
2001), which makes the procedure complicated, stressful, and particularly, difficult to 
control in that the time for the diffusion of CPAs into the cells to reach equilibrium usually 
takes at least 5-10 minutes (He et al. 2008b; Heng et al. 2005; Jain and Paulson 2006; Pedro et 
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al. 2005). In addition, a cocktail of various CPAs rather than one CPA has been commonly 
used to reduce the CPA toxicity. 
 
Slow-freezing          Low-CPA vitrification         Conventional vitrification 
Drawbacks Advantages Advantages Drawbacks 
Cell injury due to   
ice formation  and
cell dehydration 
Low, non-toxic 
CPA (≤ ~ 1.5 M)
Negligible 
ice formation and 
negligible 
cell dehydration 
High CPA (4-7 M) 
induced metabolic 
and osmotic injury 
Table 1. A summary of the major advantages and drawbacks of the commonly used slow-
freezing and conventional vitrification approaches for cell cryopreservation today: The low-
CPA vitrification approach combines all the advantages of the two commonly used 
approaches while avoiding their shortcomings 
The inherent drawbacks associated with the two conventional approaches can result in 
damage that is (mild to many other types of cells though) sufficient to induce and/or 
accelerate apoptosis (programmed cell death or cell suicide) in dissociated ES cells 
considering that the ES cells are particularly susceptible to apoptosis (Heng et al. 2009; Heng 
et al. 2006; Martin-Ibanez et al. 2008). This may explain why adding ROCK (Rho-associated 
kinase) inhibitors in the cryopreservation medium to inhibit apoptosis can significantly 
improve the survival and function of human ES cells post cryopreservation (Baharvand et 
al. 2010; Claassen et al. 2009; Heng et al. 2007; Martin-Ibanez et al. 2008). Although keeping 
ES cells in aggregates (embryonic body or EB) can reduce apoptosis, it is even more difficult 
to cryopreserve the aggregates by either slow-freezing or conventional vitrification. 
Moreover, sub-optimal cryopreservation can induce epigenetic changes and impose a 
selection bias for their outgrowth (Baran and Ware 2007). Therefore, it is of great importance 
to achieve low-CPA vitrification of ES cells in that it combines all the advantages of the two 
conventional approaches while avoiding all their shortcomings, as demonstrated in Table 1. 
A recent study has demonstrated that an ultrafast cooling rate (~200,000 oC/min) can be 
achieved by plunging a 200 µm (outer diameter), thin-walled (10 µm) quartz microcapillary 
(QMC, Fig. 2) into liquid nitrogen (He et al. 2008b). With this QMC ultrafast vitrification 
technique, R1 ES cells can be vitrified at a CPA concentration of as low as 2.5 M altogether 
(He et al. 2008b). Figure 9A shows the immediate (within 3 hr) and 1 day viability of the 
cells post cryopreservation using various CPAs. Only a small percentage of cells (~ 20%) can 
survive when using 2 M PROH (1,2-propanediol) alone as the CPA. When adding 0.5 M 
trehalose into the solution, however, the immediate cell viability increased to ~ 80%, even 
though trehalose could not permeate the cell membrane and was present only 
extracellularly. The immediate cell viability for cells cryopreserved using 0.5 M trehalose 
alone was ~ 65%. 
Unlike the immediate viability, only few cells were able to survive at day 1 when using 0.5 
M extracellular trehalose (< 2%) as the sole CPA (Fig. 9A). This result indicates the necessity 
of intracellular CPA to protect cells from within during cryopreservation. Similarly, only a 
minimal number of cells were able to survive at day 1 when using 2 M PROH (~12%) as the 
sole CPA. The 1 day viability, however, was much higher (~ 72%) when the cells were 
cryopreserved using the combination of 0.5 M extracellular trehalose and 2 M cell 
membrane permeable CPA (PROH). Therefore, PROH and extracellular trehalose appear to 
have a synergistic effect on protecting the ES cells from damage during vitrification. Such 
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synergistic interaction between trehalose and PROH/DMSO has also been observed in other 
studies (Dash et al. 2008; Wusteman et al. 2003). The proliferation/growth of the attached ES 
cells post cryopreservation using the combination of 0.5 M trehalose and 2 M PROH was 
similar to that of the control (fresh) cells over a 3-day observation period (Fig. 9B).  
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Fig. 9. (Adapted from (He et al. 2008b)) (A) Immediate and 1 day viability of fresh (No Cryo) 
cells and cells cryopreserved using 0.5 M trehalose (0.5 M Tre), 2 M PROH (1,2-
propanediol), and the combination of 0.5 M trehalose and 2 M PROH (Tre&PROH); (B) 
normalized (to the data at day 1) proliferation  of fresh and cryopreserved (using 0.5 M 
trehalose and 2 M PROH) cells over three days in culture; and micrographs showing 
undifferentiated properties of the ES cells post vitrification:  (C) staining for the surface 
glycoprotein SSEA-1, (D) green fluorescence protein (GFP) expression denoting 
transcriptional activity, (E) merged view of SSEA-1, GFP and nuclei staining (in blue using 
DAPI), (F) phase contrast image of two ES cell colonies, and alkaline phosphatase expression 
viewed at both high (G) and low (H) magnifications 
Typical Micrographs showing the undifferentiated properties of the ES cells post 
vitrification are given in Fig. 9C-H. Preservation of the undifferentiated properties were 
verified by the high level staining of the membrane surface glycoprotein SSEA-1 (C) and 
expression of GFP (green fluorescence protein) under the control of the transcription factor 
OCT-4 (D). The merged view (E) of the red (SSEA-1), green (GFP), and blue (DAPI to stain 
cell nuclei) channels indicates extensive co-expression of the two markers overlapping with 
the cell nuclei. The phase image (F) shows cells with high nuclei/cytoplasm ratios and 
compact colony formation typical of pluripotent mouse ES cells. The histochemical staining 
www.intechopen.com
Preservation of Embryonic Stem Cells 
 
129 
shows strong expression for alkaline phosphatase at high magnification (G) which was well 
distributed within each colony as observed at a lower magnification (H). These results 
suggest that the ES cells retained their undifferentiated properties post cryopreservation by 
ultrafast vitrification at the reduced CPA concentration (2.5 M altogether). Further studies to 
test the capability of the cryopreserved cells in differenriating into different types of cells in 
vitro and forming specific tissue in vivo are necessary to ultimately confirm preservation of 
the pluripotent properties of the cells after vitrification using the reduced CPA. 
6. Outlook 
Although the use of QMC can significantly reduce the required CPA concentration for ES 
cell vitrification from 4-7 M to 2.5 M, it is desired to further decrease the CPA concentration 
to ≤ 1.5 M which is usually used for slow-freezing. Therefore, it is of great interest and 
importance to further test the efficacy of the low-CPA vitrification technique in preserving 
the more stress sensitive ES cells by encapsulating the ES cells in small alginate 
microcapsules. The other advantage of microencapsulating the ES cells for vitrification is 
that the microencapsulated ES cells can be used directly for transplantation in vivo, provided 
that the wall permeability of the microcapsules is low enough to exclude immunoglobulin 
and other immunological factors from getting into the microcapsules to kill the 
encapsulated cells. The latter allows the use of non-autologous cells for the treatment of 
diseases, which significantly expands the capability of the ES cell-based medicine. 
Ultimately, it is important to achieve lyopreservation of ES cells at ambient temperature to 
allow convenient and wide distribution of the ES cell-based medicine to end users (just like 
what we are doing with lyophilized pharmaceutical drugs today), particulalry those in 
remote areas. However, no successful and consistent lyopreservation of mammalian cells 
(not to mention ES cells) has been reported in the literature. Hopefully, with the advances of 
modern nanotechnology for the intracellular deliver of small hydrophilic molecules 
(disaccharide such as trehalose)  and our understanding on anhydrobiotism in nature and 
the biophysics of freeze-drying and evaporative drying, lyopreservation of ES cells can be 
realized in the near future. 
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